Allergan Acquires Kythera Bio For $2.1 Billion

Allergan announced today that it will buy Kythera Bio for $2.1 billion dollars or $75 per share as a cash and equity type deal. Although the closing of this deal is dependent on customary closing conditions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.